Table 1.
Clinical characteristics of controls and HT patients.
| Character | Control (n=866) | HT-C (n=393) | HT+C (n=44) | P-value |
|---|---|---|---|---|
| Goiter degree | <0.0001 | |||
| None | 859 (99.19%) | 36 (9.16%) ↓ | 1 (2.27%) ↓ | |
| I | 3 (0.35%) | 183 (46.56%) ↑ | 13 (29.55%) ↑ | |
| II | 2 (0.23%) | 165 (41.98%) ↑ | 29 (65.91%) ↑ | |
| III | 2 (0.23%) | 9 (2.29%) ↑ | 1 (2.27%) ↑ | |
| Age (years) | 54.06 ± 13.50 | 47.66 ± 13.09 ↓ | 51.45 ± 11.86 ↓ | <0.0001 |
| BMI (kg/m2) | 24.49 ± 3.31 | 23.15 ± 3.55 ↓ | 24.64 ± 3.31 ↑ | <0.0001 |
| Gender | <0.0001 | |||
| Male | 508 (58. 66%) | 49 (12.47%) ↓ | 8 (18.18%) ↓ | |
| Female | 358 (41.34%) | 344 (87.53%) ↑ | 36 (81.82%) ↑ | |
| Diabetes | 0.0433 | |||
| Yes | 28 (3.23%) | 24 (6.11%) ↑ | 3 (6.82%) ↑ | |
| No | 838 (96.77%) | 369 (93.89%) ↓ | 41 (93.18%) ↓ | |
The table shows the statistics of clinical characteristics and laboratory results of controls, HT patients and patients with thyroid cancer. There were significant differences in most factors between controls and HT patients. BMI, body mass index. P-values were calculated by Kruskal–Wallis H test or Chi-square test among the triple groups.
Symbols "↓ and ↑" represent “reduced and increased” change in mean values compared to corresponding controls.